Covaxin effective against COVID-19 variants: Study |
Clinical News
eMediNexus Coverage from: 
Covaxin effective against COVID-19 variants: Study

0 Read Comments                

India’s indigenous COVID-19 vaccine, Bharat Biotech’s Covaxin, has been found to be effective against SARS-CoV-2 variants, including the delta variant which was first detected in India, in a study by the Indian Council of Medical Research.The investigation, pending peer review, also noted that the vaccine was three times as effective in developing antibodies as a prior COVID-19 infection. Furthermore, the vaccine was reported to create 2.7 times less neutralizing titre against the delta variant and three-fold less neutralizing titre against the beta variant of the coronavirus, which was first detected in South Africa. However, the vaccine was effective against both strains… (HT, June 9, 2021)...
To Read or comment on this article,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now